1-7 of 7
Jilong Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Single Cycle Blinatumomab Plus VP Chemotherapy for High Tumor Burden Acute Lymphoblastic Leukemia in Adults

Sanfang Tu, Kecheng Wang, Chaoyang Song, Xuan Zhou, Dan Xiong, Guinian Huang, Jia Feng, Jilong Yang, Bo Jin, Bo Wang, Langqi Wang, Yaqi Zhuo, Huifang Chen, Yuhua Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 5818.
https://doi.org/10.1182/blood-2023-184746
Published: 2023
Journal Articles

Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Strategy with Dual Targeting of CD19 and CD70 to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Sanfang Tu, Lijuan Zhou, Rui Huang, Xuan Zhou, Jilong Yang, Meifang Li, Bo Jin, Langqi Wang, Yaqi Zhuo, Huifang Chen, Lung-Ji Chang, Yuhua Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 3492.
https://doi.org/10.1182/blood-2023-186888
Published: 2023
Journal Articles

Dendritic Cell Vaccines Extend CD19 CAR-T Cell Persistence and Improve the Outcomes in Refractory/Relapsed Adult B-ALL

Sanfang Tu, Lijuan Zhou, Rui Huang, Yanjie He, Xuan Zhou, Jilong Yang, Yuxing Hu, Honghao Zhang, Lung-Ji Chang, Yuhua Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 3488.
https://doi.org/10.1182/blood-2023-186308
Published: 2023
Journal Articles

Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Combined with Zanubrutinib in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Langqi Wang, Jilong Yang, Bo Jin, Bo Wang, Lijuan Zhou, Yaqi Zhuo, Huifang Chen, Lung-Ji Chang, Sanfang Tu, Yuhua Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 4841.
https://doi.org/10.1182/blood-2023-186439
Published: 2023
Journal Articles

Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD22 to Treat Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults

Sanfang Tu, Lijuan Zhou, Rui Huang, Xuan Zhou, Jilong Yang, Meifang Li, Bo Jin, Langqi Wang, Yaqi Zhuo, Huifang Chen, Lung-Ji Chang, Yuhua Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6884.
https://doi.org/10.1182/blood-2023-186622
Published: 2023
Journal Articles

A Novel Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD123 to Treat Relapsed Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Sanfang Tu, MD PhD, Lan Deng, MD PhD, Rui Huang, MD PhD, Xuan Zhou, MD, Jilong Yang, MD, Weijun Zhou, MD PhD, Meifang Li, MD PhD, Chunyan Yue, MD, Shaojie Wu, MD PhD, Zhenling Guo, Lung-Ji Chang, PhD, Yuhua Li, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4015.
https://doi.org/10.1182/blood-2018-99-118526
Published: 2018
Journal Articles

Therapy of 4s Chimeric Antigen Receptor T Cells Achieves Long-Term Disease-Free Survival with No Severe CRS or Cres in Patients with Relapsed and Refractory Acute Lymphoblastic Leukemia

Sanfang Tu, MD PhD, Rui Huang, MD PhD, Lan Deng, MD PhD, Xuan Zhou, MD, Yanjie He, MD PhD, Weijun Zhou, MD PhD, Jilong Yang, MD, Chunyan Yue, MD, Anqin Wu, Meifang Li, MD PhD, Zhenling Guo, Lung-Ji Chang, PhD, Yuhua Li, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2696.
https://doi.org/10.1182/blood-2018-99-118928
Published: 2018